ArticleBMJ open2025
Prevalence of mild cognitive impairment among former elite athletes without a history of sport-related concussions compared to the general older population: a protocol for a cross-sectional study with exploratory subgroup analyses.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEpidemiological evidence regarding the impact of elite athletic careers on cognitive trajectories remains contentious. Although consistent physical activity has been associated with long-term brain health, former elite athletes appear to represent a unique population. While past research has established a connection between sport-related concussions (SRCs) and later cognitive decline, less attention has been given to the cognitive function of former athletes who have not experienced SRCs. Therefore, well-structured cross-sectional studies accounting for established dementia risk factors are needed to compare mild cognitive impairment (MCI) prevalence between former elite athletes and the general population. METHODS AND ANALYSIS: This cross-sectional study will be conducted at Beijing Sport University (BSU) in Beijing, China. It is designed as a comparative study, aiming to recruit a sample of around 360 participants aged 65 and above. This sample will comprise 180 former elite athletes without a history of SRCs recruited via the BSU Retirement Welfare Office (the former athlete group), and 180 age-matched individuals from the communities in three districts in Beijing (the comparison group). Participants will complete a comprehensive questionnaire covering sociodemographic information, dementia-related risk factors, current physical activity levels and, for the former athlete group specifically, details of their athletic careers. MCI and instrumental activities of daily living will be assessed using the Montreal Cognitive Assessment, Memtrax continuous recognition test and Lawton Instrumental Activities of Daily Living (IADL) scale. The primary objective is to determine whether former elite athletes without a history of SRCs have a lower MCI prevalence than the general population. The secondary objective is to assess if these former elite athletes have a reduced prevalence of amnestic MCI and impairment in IADL compared with the general population. Additionally, the study aims to explore whether specific career-related characteristics of former athletes, such as the type of sport and contact exposure, are correlated with their cognitive function and IADL abilities in later life as a secondary exploratory component. The study will calculate the crude prevalence ratios (PRs) and adjusted prevalence ratios (aPRs) with 95% CIs using the modified Poisson regression model with robust error variance. ETHICS AND DISSEMINATION: Ethical approval was obtained from the Ethics Committee/Internal Review Board of BSU (approval number: 2024042H). All procedures will adhere to the Helsinki Declaration. The study's findings will be provided to participants as deemed appropriate. The outcomes will be communicated through abstract presentations at national or international conferences/academic seminars, as well as through publication in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: ChiCTR2400085800.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.